SG Americas Securities’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
SG Americas Securities's BNTX Position: Q1 2026 in Review
SG Americas Securities reduced its BioNTech (BNTX) stake by 26% in Q1 2026, selling an estimated $9.77M and leaving 270,245 shares worth $24M. The position accounts for 0.03% of the portfolio, ranked #477.
SG Americas Securities first reported a position in BNTX in Q1 2020 and has held it in 25 quarters since. The position peaked at $45.5M in Q4 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.
- SG Americas Securities held 270,245 shares of BioNTech worth $24M as of Q1 2026.
- SG Americas Securities sold 95,088 BioNTech shares in Q1 2026, an estimated $9.77M.
- BioNTech made up 0.03% of SG Americas Securities's portfolio in Q1 2026, its #477 holding.
- SG Americas Securities first reported a position in BioNTech in Q1 2020 and has held it in 25 quarters since.
- SG Americas Securities's BioNTech position peaked at $45.5M in Q4 2021.
- 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.